References
Fuchs RK, Allen MR, Condon KW, Reinwald S, Miller LM, McClenathan D, Keck B, Phipps RJ, Burr DB (2008) Strontium ranelate does not stimulate bone formation in ovariectomized rats. Osteoporos Int 19:1331–1341, doi:10.1007/s00198-008-0602-6
Meunier PJ et al (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350:459–468
Reginster JY et al (2005) Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab 90:2816–2822
Marie PJ et al (1993) An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats. J Bone Miner Res 8:607–615
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
A reply to this letter can be found at http://dx.doi.org/10.1007/s00198-008-0741-9.
Rights and permissions
About this article
Cite this article
Marie, P.J. Effective doses for strontium ranelate. Osteoporos Int 19, 1813 (2008). https://doi.org/10.1007/s00198-008-0740-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-008-0740-x